Oct. 2 at 8:06 PM
$CRDF Two-Fer =
SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc.(CRDF) , a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will participate in two upcoming investor conferences in October 2025.
Details of the events can be found below.
Piper Sandler Virtual Oncology Symposium
Format: Fireside Chat
Presenters: Mark Erlander, PhD (CEO), James Levine (CFO), and Roger Sidhu, MD (CMO)
Date: 10/09/2025
Time: 1:00 PM ET
Contact Piper Sandler for information on attending the conference.
Noble Capital Markets’ Emerging Growth Virtual Equity Conference
Format: Fireside Chat
Presenter: Mark Erlander, CEO
Date: 10/09/2025
Time: 2:00 PM ET